Vincenzo De Leo

ORCID: 0000-0001-8522-9370 · 25 papers in corpus
rct 2020
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception ·doi:10.1080/13625187.2020.1736546

Objectives: The aim of the study was to update the results of a previous study published 10 years ago and compare the effect on hyperandrogenism of a newer progestin, dienogest (DNG), in a combined oral contraceptive (COC) formulation with …

lab-animal 2020
Cells ·doi:10.3390/cells9051121

Embryo implantation has been defined as the "black box" of human reproduction. Most of the knowledge on mechanisms underlining this process derives from animal models, but they cannot always be translated to humans. Therefore, the developme…

rct 2020
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-020-00611-1

BACKGROUND: The presence of submucous fibroids strongly impacts on IVF results, therefore, these patients should be considered for surgical or medical treatment. The aim of this study was to assess the role of Ulipristal acetate (UPA), a se…

other 2019
Cells ·doi:10.3390/cells8080811

Despite the significant advances in the last decades, low implantation rate per transferred embryo still remains a major concern in assisted reproductive techniques, highlighting a need to better characterize endometrial receptivity also by…

nonrandomized-trial 2019
Minerva ginecologica ·doi:10.23736/S0026-4784.19.04384-3

BACKGROUND: Dysmenorrhea and chronic pelvic pain occur in a significantly higher percentage in women with endometriosis; this benign condition has an incidence ranging from 5% to 10% in the general population, while 35% to 50% of infertile …

review 2018
Minerva ginecologica ·doi:10.23736/s0026-4784.17.04157-0

In the last few years new oral contraceptives have been marketed showing a better safety profile for women. They are the result of important changes made to the old compounds. As far as the estrogenic component, with the aim of decreasing s…

other 2018
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719117718276

Glycodelin-A (GdA) has been proposed to represent a potential biomarker of endometrial function, but little is known about its expression during the different phases of the menstrual cycle and under pathological conditions. In the light of …

review 2018
Minerva ginecologica ·doi:10.23736/s0026-4784.17.04172-7

Vitamin D or calcitriol, which was first identified back in 1920, has a key role in bone metabolism and mineralization, and in calcium and magnesium homeostasis. A nuclear receptor (VDR) mediates vitamin D actions in a lot of organs like bo…

nonrandomized-trial 2016
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-016-0184-7

BACKGROUND: The status characterized by the imbalance between pro-oxidants and antioxidants molecules, defined as oxidative stress, has been suggested to be involved in the pathogenesis of subfertility in females. This study aims to evaluat…

other 2014
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719114522549

The present study investigated expression and protein localization of FOXL2 messenger RNA (mRNA) in endometrium of healthy women and in patients with endometriosis during endometrial cycle. In endometriotic lesions, FOXL2 mRNA and protein w…

nonrandomized-trial 2013
Contraception ·doi:10.1016/j.contraception.2012.09.003

BACKGROUND: Insulin resistance may be induced by both the estrogen and progestin component in hormonal contraception. When estrogen dose is reduced from 50 to 20 mcg, the extent of hyperinsulinemia decreases. Recently, the oral combination …

2011
2011
·doi:10.1093/humrep/26.s1.80
review 2011
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719111405068

The role of sex steroid hormones in reproductive function in women is well established. However, in the last two decades it has been shown that receptors for estrogens, progesterone and androgens are expressed in non reproductive tissue /or…

review 2007
Best practice & research. Clinical obstetrics & gynaecology ·doi:10.1016/j.bpobgyn.2007.07.005

Hormonal changes are involved in several gynaecological disorders. Correct functioning of the hypothalamus-pituitary-ovarian (HPO) axis is critical for ovulatory function, as well as the growth and differentiation of uterine tissue (myometr…

rct 2007
Fertility and sterility ·doi:10.1016/j.fertnstert.2006.11.151

OBJECTIVE: To evaluate the effects after 10 days of an original treatment combining oral progestins with vaginal raloxifene to maximize the antiproliferative effect on the endometrium. DESIGN: Prospective, randomized, clinical pilot study.…

other 2003
Fertility and sterility ·doi:10.1016/s0015-0282(03)00070-0
other 2003
Journal of assisted reproduction and genetics ·doi:10.1023/a:1024111629191

PURPOSE: To investigate whether inhibin B and activin A serum and follicular fluid levels in infertile women undergoing induction of superovulation correlate with successful ovulation. METHODS: Infertile women (n = 16) (30-43 years of age)…

review 2002
Drug safety ·doi:10.2165/00002018-200225110-00002

The growth of a uterine leiomyoma growth stops and regresses after the menopause suggesting that leiomyoma growth is dependent on ovarian steroids. Therefore, estrogen has received much attention as the major factor responsible for the deve…

other 2002
Fertility and sterility ·doi:10.1016/s0015-0282(01)03234-4

OBJECTIVE: To evaluate the course of changes in serum inhibin A, inhibin B, and pro-alphaC levels in women with surgically or pharmacologically induced menopause. DESIGN: Longitudinal study. SETTING: Academic Health Center of Siena, Siena…

rct 1999
Human Reproduction ·doi:10.1093/humrep/14.9.2371

The most effective therapy for endometriosis is a matter for debate. The aim of the present randomized study was to evaluate the efficacy of low doses of danazol on recurrence of pelvic pain in patients with moderate or severe endometriosis…

nonrandomized-trial 1999
Gynecologic and obstetric investigation ·doi:10.1159/000010118

The aim of this study was to evaluate the effects of danazol in reducing the volume of fibromyomas and in the treatment of associated symptoms. Twenty women (34-42 years) with uterine fibromyomas were treated with 400 mg/day of danazol for …

1998
nonrandomized-trial 1997
Human Reproduction ·doi:10.1093/humrep/12.2.357

We report the results of administration of danazol after suspension of gonadotrophin-releasing hormone analogue (GnRHa) therapy for uterine myomas. A total of 21 women with uterine myomas was treated with 100 mg danazol for 6 months after G…

review 1996
Minerva ginecologica

Uterine fibromyomatosis is a widely recognised and well studied pathology that is found in around 30% of over 35-year-old women. It has been extensively demonstrated that the etiology of fibromyomas is hormone dependent and to date the main…